Literature DB >> 3768364

Relationship between antimicrobial activity and amphiphilic property of basic model peptides.

S Lee, H Mihara, H Aoyagi, T Kato, N Izumiya, N Yamasaki.   

Abstract

Several cationic model peptides of the prepiece moieties of mitochondrial protein precursors were found to be active against Gram-positive bacteria, but inactive against Gram-negative bacteria. The CD spectra of the model peptides in the presence of phospholipid liposomes demonstrated that antimicrobial activity was generally in parallel with the content of the alpha-helical amphiphilicity. The results indicate that appropriate positioning of cationic and hydrophobic groups in the stable alpha-helical structure of the peptides is important to exhibit antimicrobial activity. These peptides also have an ability to leak carboxyfluorescein from acidic and neutral phospholipid vesicles, suggesting that the peptides interact with the bacterial membrane to perturb it.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768364     DOI: 10.1016/0005-2736(86)90485-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.

Authors:  R P Darveau; J Blake; C L Seachord; W L Cosand; M D Cunningham; L Cassiano-Clough; G Maloney
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Partially folded rhodanese or its N-terminal sequence can disrupt phospholipid vesicles.

Authors:  J A Mendoza; E Grant; P M Horowitz
Journal:  J Protein Chem       Date:  1993-02

3.  Role of proline, cysteine and a disulphide bridge in the structure and activity of the anti-microbial peptide gaegurin 5.

Authors:  Sang-Ho Park; Hyung-Eun Kim; Chi-Man Kim; Hee-Jeong Yun; Eung-Chil Choi; Bong-Jin Lee
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

4.  Apidaecins: antibacterial peptides from honeybees.

Authors:  P Casteels; C Ampe; F Jacobs; M Vaeck; P Tempst
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.